ITGAM and glioblastoma: Relative amounts of CD45+ and CD11b+ cells were similar in low-grade and GBM tumors and the median ages at diagnosis were 44 ± 4.9 years old versus 54.3 ± 4.1 years old for low-grade and GBM, respectively (Extended Data Fig. 9b,c).